Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Macular Edema
- Diabetic Retinopathy
- Retinal Ischemia
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04038125
- Collaborators
- Allergan
- Investigators
- Principal Investigator: Diana Shechtman, OD FAAO Retina Macula Specialists of Miami, LLC
Get Well Soon